Contact this trialFirst, we need to learn more about you.
Platinum-based Chemotherapy
MK-7684A + Chemotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Rochester, Minnesota
This trial is testing whether adding MK-7684A to chemotherapy helps people with NSCLC live longer without their disease getting worse, and whether it helps people live longer overall, compared to adding pembrolizumab to chemotherapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.